AMEX · IHE
iShares U.S. Pharmaceuticals ETF
$107.61+$1.00 (+0.94%)
iShares U.S. Pharmaceuticals ETF’s quoted price sits in the upper half of its reported 52-week range, 1.66% below the high.
Loading market information…
NASDAQ · FYC · USD
Stock price, dividends
Quote as of Oct 30, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
First Trust Small Cap Growth AlphaDEX Fund’s quoted price sits in the upper half of its reported 52-week range, 10.61% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
First Trust Small Cap Growth AlphaDEX Fund’s forward annual dividend is $0.16 per share, paid semi-annual. The forward yield is 0.14% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
THE COMPANY BEHIND THE TICKER
First Trust Exchange-Traded AlphaDEX Fund - First Trust Small Cap Growth AlphaDEX Fund is an exchange traded fund launched and managed by First Trust Advisors LP. It invests in public equity markets of the United States. It invests in stocks of companies operating across diversified sectors. It invests in growth stocks of small-cap companies. The fund seeks to track the performance of the Nasdaq AlphaDEX Small Cap Growth Index, by using full replication technique. First Trust Exchange-Traded AlphaDEX Fund - First Trust Small Cap Growth AlphaDEX Fund was formed on April 19, 2011 and is domiciled in the United States.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 31, 2026, 10:15 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
KEEP COMPARING
$107.61+$1.00 (+0.94%)
iShares U.S. Pharmaceuticals ETF’s quoted price sits in the upper half of its reported 52-week range, 1.66% below the high.
$33.54-$0.32 (-0.95%)
Invesco International Developed Dynamic Multifactor ETF’s quoted price sits in the upper half of its reported 52-week range, 7.55% below the high.
$119.33+$2.41 (+2.06%)
VanEck Pharmaceutical ETF’s quoted price sits in the upper half of its reported 52-week range, 1.27% below the high.
$161.30+$0.07 (+0.04%)
Vanguard U.S. Value Factor ETF’s quoted price sits in the upper half of its reported 52-week range, 1.66% below the high.
$88.55-$1.21 (-1.35%)
First Trust Developed Markets ex-US AlphaDEX Fund’s quoted price sits in the upper half of its reported 52-week range, 12.6% below the high.
$45.25+$0.24 (+0.54%)
Franklin U.S. Low Volatility High Dividend Index ETF’s quoted price sits in the upper half of its reported 52-week range, 2.69% below the high.
$55.91-$1.06 (-1.85%)
Strategy Shares Day Hagan Smart Sector ETF’s quoted price sits in the upper half of its reported 52-week range, 2.57% below the high.
$31.02-$0.49 (-1.55%)
First Trust Emerging Markets AlphaDEX Fund’s quoted price sits in the upper half of its reported 52-week range, 12.89% below the high.
